Company Description

Scientific Breakthroughs Happen Every Day. Many of them never make it past the lab, as they aren't socially or economically feasible. Organicin is a venture-backed biotech company that has pioneered a proprietary bacteriocin discovery platform that overcomes major obstacles in antibacterial drug discovery; such as costs, efficacy & safety, resistance, and sustainability. Bacteriocins are not antibiotics. They are proteins produced by bacteria for the sole purpose of protecting their host against competing bacteria and are a powerful weapon in the fight against antibiotic resistance. Different from broad-spectrum antibiotics, they are highly targeted antimicrobials that inhibit growth of specific strains of bacteria, without harming the gut microbiome.